ÂÜÀòÂÒÂ×

Krzysztof B Wicher has a strong background in drug discovery and development. In 2020, they joined Macomics as the Senior Vice President of Drug Discovery and Development. Prior to that, they worked at Kymab Ltd as the Director of Pharmacology and Translational Sciences from 2019 to 2020. Krzysztof B also held positions at Ossianix as the Director of Research, Principal Senior Scientist and Group Leader, and Senior Research Scientist. At MedImmune, they worked as a Scientist specializing in antibody and protein engineering and expression. Krzysztof B started their career at the University of Cambridge's Gurdon Institute as a Research Associate/PostDoc, and later joined Cancer Research UK as a PostDoc. Krzysztof B completed their PhD at Uppsala University.

Krzysztof B Wicher has a solid educational background in the field of biochemistry and biotechnology. Krzysztof B obtained their PhD in Medical Biochemistry from Uppsala University, Sweden, from 2001 to 2006. Prior to that, they completed their MSc in Biotechnology at Jagiellonian University, Poland, from 1995 to 2000. Their earlier education includes studying Chemistry at VLO from 1991 to 1995.

In addition to their formal education, Krzysztof has pursued further certifications to enhance their skills and knowledge. Krzysztof B obtained a certificate in "Learning Julia" from LinkedIn in March 2020, and another one in "Laboratory Animal Handling" from the UK Home Office in September 2011. Krzysztof B has also completed various online courses through edX, including "Fundamentals of Clinical Trials," "Introduction to R Programming," and "Software as a Service," for which they received Honor Code Certificates.